Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
11.29
+0.49 (4.54%)
At close: May 4, 2026, 4:00 PM EDT
11.46
+0.17 (1.52%)
After-hours: May 4, 2026, 7:38 PM EDT
Artiva Biotherapeutics Market Cap
Artiva Biotherapeutics has a market cap or net worth of $279.05 million as of May 4, 2026. Its market cap has increased by 397.99% in one year.
Market Cap
279.05M
Enterprise Value
181.74M
1-Year Change
397.99%
Ranking
Category
Stock Price
$11.29
Market Cap Chart
Since the IPO on July 19, 2024, Artiva Biotherapeutics's market cap has increased from $176.76M to $279.05M, an increase of 57.87%. That is a compound annual growth rate of 29.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 266.94M | 153.51% |
| Dec 31, 2025 | 105.30M | -56.99% |
| Dec 31, 2024 | 244.84M | 38.52% |
| Jul 19, 2024 | 176.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cellectis | 283.24M |
| Eledon Pharmaceuticals | 280.32M |
| Foghorn Therapeutics | 279.41M |
| LENZ Therapeutics | 278.43M |
| Coherus Oncology | 277.59M |
| NovaBridge Biosciences | 275.24M |
| Minerva Neurosciences | 266.12M |
| Alector | 260.46M |